Mechanism of Jianpi Xiaoai Prescription in Inhibiting Colon Cancer Proliferation

LUO Yan; LUO Ji; JIANG Yi-lan; LI Yong-min; TAN Xiao-ning; LYU Yuan; MA Rong-li

doi:10.13422/j.cnki.syfjx.20180683

您当前的位置：

首页 >

文章列表页 >

Mechanism of Jianpi Xiaoai Prescription in Inhibiting Colon Cancer Proliferation

更新时间：2024-01-04

- Mechanism of Jianpi Xiaoai Prescription in Inhibiting Colon Cancer Proliferation
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 6, Pages: 151-155(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20180683
  CLC： R285
- Published：2018
- 稿件说明：
移动端阅览
LUO Yan, LUO Ji, JIANG Yi-lan, et al. Mechanism of Jianpi Xiaoai Prescription in Inhibiting Colon Cancer Proliferation[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(6): 151-155.
DOI：

LUO Yan, LUO Ji, JIANG Yi-lan, et al. Mechanism of Jianpi Xiaoai Prescription in Inhibiting Colon Cancer Proliferation[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(6): 151-155. DOI： 10.13422/j.cnki.syfjx.20180683.

摘要

目的：观察健脾消癌方对结肠癌HCT116细胞中微小RNA-21（microRNA-21，miR-21），第10号染色体丢失的磷酸酶基因（phasphatase and tensin homo-log deleted in chromosome 10，PTEN）表达的影响，探讨健脾消癌方抑制结肠癌转移的可能作用机制。方法： 10%，15%，20%健脾消癌方含药血清处理HCT116细胞后，实时荧光定量PCR （Real-time PCR）检测miR-21，PTEN mRNA的表达水平，蛋白免疫印迹法（Western blot）检测PTEN蛋白的表达水平。结果：与空白组比较，健脾消癌方低剂量组miR-21 mRNA相对表达量降低，PTEN mRNA相对表达量升高，但差异无统计学意义；健脾消癌方中剂量组miR-21 mRNA相对表达明显降低，PTEN mRNA相对表达明显升高（P<0.05）；健脾消癌方高剂量组miR-21 mRNA相对表达量显著降低，PTEN mRNA相对表达量显著升高（P<0.01）；与健脾消癌方中、低剂量组比较，健脾消癌方高剂量组miR-21 mRNA相对表达量明显降低，PTEN mRNA相对表达量明显升高（P<0.05）。与空白组比较，健脾消癌方中、低剂量组PTEN蛋白相对表达量升高，差异无统计学意义；与空白组比较，健脾消癌方高剂量组PTEN蛋白相对表达量明显上升（P<0.05）；与健脾消癌方中、低剂量组比较，健脾消癌方高剂量组PTEN蛋白相对表达量明显升高（P<0.05）。结论：健脾消癌方可能通过降低miR-21的表达，上调miR-21靶基因PTEN蛋白表达抑制结肠癌的增殖。

Abstract

Objective: To observe the effect of Jianpi Xiaoai prescription on the expressions of microRNA-21 (miR-21)

phasphatase and tensin homo-log deleted in chromosome 10 (PTEN) in colon cancer HCT116 cells

in order to investigate the possible mechanism of Jianpi Xiaoai prescription on the metastasis of colon cancer.Method: After the treatment with drug serum (10%

15% and 20%)

Real-time PCR was used to detect the mRNA expressions of miR-21

PTEN

and the protein expression of PTEN was detected by Western blot.Result: Compared with control group

the relative mRNA expression of miR-21 was decreased

while the relative mRNA expression of PTEN was significantly increased in the low-dose Jianpi Xiaoai prescription group. Compared with control group

the relative mRNA expression of miR-21 in high-dose group was statistically lower

while the mRNA relative expression of PTEN in high-dose group was higher (P<0.05). Compared with the low and middle-dose groups

the relative mRNA expression of miR-21 in high-dose group was decreased

while the relative mRNA expression of PTEN was significantly increased (P<0.05). Compared with control group

the relative protein expression of PTEN in high-dose group was significantly higher than that in low-dose group (P<0.05). The relative protein expression of PTEN in high-dose group was higher than that in low-dose group and middle-dose groups (P<0.05).Conclusion: Jianpi Xiaoai prescription can inhibit the proliferation of colon cancer by reducing the expression of miR-21 and improving the expression of anti-cancer protein PTEN.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy of Jianpi Xiaoai Prescription in Inhibition of Metastasis of Colon Cancer HCT116 Cells： An Exploration Based on LncRNA HOTAIR/JAK2/STAT3 Signaling Pathway

Tongxie Yaofang Regulates Expression of NKG2DL to Enhance Anti-tumor Effect of NK Cells in Colon Cancer under Chronic Stress

Yangyin Huayu Jiedu Preseription Regulates Autophagy and Apoptosis of Colon Cancer Cells in Hypoxic Environment Through PI3K/Akt Signaling Pathway

Inhibitory Effect and Mechanism of Sishenwan-containing Serum on Aerobic Glycolysis in Human Colon Cancer Cells

Mechanism of Huangqintang in Treatment of Ulcerative Colitis and Related Colon Cancer： A Review

Related Author

Jiao JIAO

Qi TANG

Yi-lan JIANG

Dong-fang LI

Jia-qin LIU

Guang-sheng HU

HU Yan'e

HUANG Yuqing

Related Institution

Hunan Academy of Traditional Chinese Medicine Affiliated Hospital

Hunan Cancer Hospital

Graduate School， Hunan University of Chinese Medicine

Cancer Institute， Chengdu University of TCM

Traditional Chinese Medicine （TCM） Regulating Metabolic Diseases Key Laboratory of Sichuan Province， Hospital of Chengdu University of TCM

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰